A board to discuss biotech and biopharma ideas -
MICRO CAP - (0 - 500 mil) -
***********************************
Intec Pharma (NTEC) - Oral drug delivery system (68 mil) ------------------- (Israel)
MEI Pharma (MEIP) - Cancer (194 mil)
VistaGen (VTGN) - Neurological (56 mil)
SMALL CAP - (500 mil - 2 Bil) -
**************************************
Bluebird Bio (BLUE) - Gene therapies (1.6 Bil)
Eagle Pharma (EGRX) Critical care, oncolgy (550 mil) (D) Enanta (ENTA) - Infectious diseases, Hep C (450 mil) ---- (D) MID CAP -
(2 Bil - 10 Bil) -
********************************
Acadia (ACAD) - Neurological, CNS (3.8 Bil)
Intercept Pharmaceuticals (ICPT) - Liver and intestinal diseases (3.5 Bil) ---- (
B)
Ionis Pharmaceuticals (IONS) - RNA-targeted drug (3 Bil)
Jazz Pharma (JAZZ) - Diverse (8.5 Bil) ---------------------------------------------- (Ireland)
Ligand (LGND) - Royalty generating pharma assets, Captisol solubility platform (2.6 Bil)
Medicines Co (MDCO) - Cardio, infectious, diseases (2.5 Bil)
Neurocrine Biosciences (NBIX) - Neurological, endocrine (3.8 Bil)
Seattle Genetics (SGEN) - Cancer, autoimmune, armed MABs (5.7 Bil)
United Therapeutics (UTHR) - Cardio, pulmonary (4.9 Bil)
LARGE CAP - (10 - 30 Bil) -
************************************
Biomarin (BMRN) - Metabolic orphan diseases, cancer (21 Bil)
Incyte (INCY) - Hematologic, cancer, inflam, autoimmune (15 Bil)
VERY LARGE CAP - (30 - 100 Bil) -
*********************************************
Abbott Labs (ABT) - Pharmaceuticals, diverse healthcare products (74 Bil)
Alexion (ALXN) - Rare diseases (44 Bil)
Biogen Idec (BIIB) - Neurodegenerative, hemophilia, autoimmune (72 Bil)
Regeneron (REGN) - Diverse clinical indications (60 Bil)
MEGA CAP - (over 100 Bil) -
************************************
AbbVie (ABBV) - Drug development arm from Abbott Labs (109 Bil)
Allergan (AGN) - Generic, branded, biosimilar, and OTC pharma products (125 Bil)
Amgen (AMGN) - Blood cell stimulators, other (131 Bil)
Bristol-Myers Squibb (BMY) - Pharmaceuticals (105 Bil)
Gilead (GILD) - Infectious diseases, HIV, Hepatitis (168 Bil)
Novartis (NVS) - Pharmaceuticals, healthcare products (246 Bil) -------------------- (Switzerland)
Novo Nordisk (NVO) - Pharma, insulin (150 Bil) --------------------------------------------- (Denmark)
Pfizer (PFE) - Pharmaceuticals (216 Bil)
Roche (RHHBY) - Pharmaceuticals, diagnostics (239 Bil) ------------------------- (Switzerland)
GENERICS -
***************
Dr Reddy's Labs (RDY) - Generics, other (7 Bil) ----------------------------------------------- (India)
Lannett (LCI) - Generic drugs (1.2 Bil)
Mylan Labs (MYL) - Generic drugs (11 Bil)
Perrigo (PRGO) - Generic / OTC drugs, consumer healthcare products (11 Bil) ------(Ireland)
Taro Pharmaceuticals (TARO) - OTC and generic drugs, active ingredients (5 Bil) --(Israel)
Teva (TEVA) - Generics, other (40 Bil) ------------------------------------------------------------ (Israel)
VETERINARY -
*******************
Idexx Labs (IDXX) - Veterinary diagnostic products and services (5 Bil)
Neogen (NEOG) - Food safety testing, animal heath (1.2 Bil)
PetMed Express (PETS) - Veterinary drugs and health products (264 mil)
Zoetis (ZTS) - Veterinary drugs and vaccines, Pfizer subsidiary (16 Bil)
DIAGNOSTICS - *******************
BioRad Labs (BIO) - Products for bio research and clinical diagnostics (2.9 Bil)
Genomic Health (GHDX) - Molecular diagnostics, genomic based lab tests (918 mil)
Myriad Genetics (MYGN) - Diagnostic tests (1.2 Bil)
RESEARCH PRODUCTS -
*********************************
Agilent (A) - Bio-analytical and electronic measurement solutions (16 Bil)
Bio-Techne (TECH) - Research + clinical diagnostic products (3 Bil)
Cambrex (CBM) - Active pharmaceutical ingredients and intermediates (380 mil)
RESEARCH PRODUCTS - CELLS -
********************************************
Organovo (ONVO) - 3-D bioprinting to create human tissues (650 mil)
ANTIBIOTICS -
********************
Innovation Pharma (IPI) - Cancer, inflam, antibiotics, acquired Polymedix, Cellceutix (184 mil)
Pfizer (PFE) - Zyvox
Roche (RHHBY) - Macrocycle antibiotics with Polyphor, arylomycins with RQx (Switzerland)
INDUSTRIAL BIOTECH -
******************************
Novozymes (NVZMY.PK) - Industrial enzymes, microorganisms, and bio ingredients -----(Denmark)
MORE **********
Advaxis (ADXS) - Cancer (450 mil) ---- (
D)
Array (ARRY) - Cancer, inflammatory (811 mil)
InVivo Therapeutics (NVIV) - Biopolymer scaffolding for spinal cord injuries (150 mil)
Momenta (MNTA) - Complex biosimilars, biogenerics (754 mil) ---- (
D)
Sarepta (SRPT) - RNA-based therapeutics for rare and infectious diseases (1.2 Bil)
Spectrum (SPPI) - Cancer, other (750 mil)
MISC -
**********
Sensient (SXT) - Flavors, colors, fragrances (2 Bil) -
CANNABIS RELATED -
*******************************
Horizons Marijuana Life Science Index (HMLSF) https://investorshub.advfn.com/Cannabis-and-Hemp-Sector-Ideas-27865/ OTHER -
************
Amyris (AMRS) - Producing diverse industrial compounds via yeast bioreactors (140 mil) Anavex (AVXL) - Neurological, CNS (210 mil) Innovation Pharma (IPI) - Cancer, inflam, antibiotics (Polymedix, Cellceutix) (168 mil) Organovo (ONVO) - 3-D bioprinting to create human tissues (352 mil) RespireRx (RSPI) - Ampakines, dronabinol, respiratory indications (Cortex) (12 mil) ACQUIRED -
****************
Abgenix (ABGX) - Monoclonal antibodies (Amgen)
Actavis (ACT) - Generics, other (merged with Allergan
Ariad (ARIA) - Cancer (Takeda)
Bio-Reference Labs (BRLI) - Clinical laboratory testing services (Opko)
Celator (CPXX) - Cancer, dosage optimized liposome encapsulated combo drugs (Jazz)
Celgene (CELG) - Cancer, inflam (Bristol-Myers Squibb) Cephalon (CEPH) - CNS (Teva) ------------------------------------------------------------------(Israel)
Cubist (CBST) - Antibiotics (Merck)
Cynapsus (CYNA) - Oral rescue med for Parkinson's disease (Canada) (Sunovion)
Durata Therapeutics (DRTX) - Antibiotics (Actavis)
Gentium (GENT) - Veno-occlusive disease (Italy) (Jazz)
Genzyme (GENZ) - Orphan diseases, other (Sanofi) --------------------------------------(France)
Given Imaging (GIVN) - Pill-Cam capsules for visualization of GI tract (Israel) (Covidien)
Idenix (IDIX) - Infectious diseases, Hep C (Merck)
Inhibitex (INHX) - Infectious diseases (BMY)
Kite Pharma (KITE) - Cancer (Gilead) Life Technologies (LIFE) - Molecular biology related products (TMO)
Medarex (MEDX) - Monoclonal antibodies (BMY)
Medivation (MDVN) - Cancer, neurological (10.3 Bil) (Pfizer)
Memory Pharma (MEMY) - CNS (Roche) ---------------------------------------------(Switzerland)
MGI Pharma (MOGN) - Oncology related (Eisai) -------------------------------------------(Japan)
Micromet (MITI) - Cancer (Amgen)
Millenium Pharma (MLNM) - Cancer (Takeda) ---------------------------------------------(Japan)
MWI Veterinary Supply (MWIV) - Veterinary drugs and products (Amerisource Bergen)
Onyx (ONXX) - Cancer (Amgen)
Optimer - Antibiotics (Cubist)
Pharmacyclics (PCYC) - Cancer, immune diseases (Abbvie)
Pharmasset (VRUS) - Infectious diseases (Gilead)
Polymedix (PYMX) - Defensin-mimetic antibiotics, other (Cellceutix)
Prolor (PBTH) - Long acting versions of therapeutic proteins (Opko)
Salix (SLXP) - GI related disorders (Valeant)
Santarus (SNTS) - GI, diabetes, other (Salix)
Senomyx (SNMX) - Taste modulators, flavor enhancing technology (Firmenich) Shire (SHPG) - Pharmaceuticals (Takeda) Sigma Aldrich (SIAL) - Bio research reagents, chemicals (Merck)
Synageva (GEVA) - Lysosomal storage disorders (Alexion)
Trius (TSRX) - Antibiotics (Cubist)
VCA Antech (WOOF) - Veterinary hospitals (Mars) ViroPhama (VPHM) - Angioedema, infectious diseases, other (Shire)